BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/1/2014 8:25:00 PM | Browse: 1117 | Download: 1088
Publication Name World Journal of Gastroenterology
Manuscript ID 6793
Country South Korea
Received
2013-10-29 10:18
Peer-Review Started
2013-10-30 07:45
To Make the First Decision
2013-12-16 17:41
Return for Revision
2013-12-18 15:13
Revised
2014-01-24 20:54
Second Decision
2014-04-09 09:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 10:58
Articles in Press
2014-05-23 11:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-15 15:34
Typeset the Manuscript
2014-09-12 16:28
Publish the Manuscript Online
2014-10-01 20:25
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection?
Manuscript Source Invited Manuscript
All Author List Jee Suk Chang, Woong Sub Koom, Youngin Lee, Hong In Yoon and Hyung Sik Lee
Funding Agency and Grant Number
Corresponding Author Hyung Sik Lee, MD, Department of Radiation Oncology, Dong-A University Hospital, 1-3 Dongdaesindong, Seo-gu, Busan 602-715, South Korea. hyslee@dau.ac.kr
Key Words Gastric cancer; D2-dissection; Recurrence; Radiotherapy; Chemotherapy
Core Tip The survival benefits of postoperative chemoradiotherapy (CRT) in gastric cancer with D0/1-dissection have been established in Western countries. However, in Eastern areas, where D2-dissection is the standard surgical procedure, most surgeons are skeptical about the benefit of CRT in D2-dissected patients, and CRT has not been examined in this setting in clinical trials. Here we aimed to provide a review of recent research and to suggest future directions regarding adjuvant CRT after D2-dissection.
Publish Date 2014-10-01 20:25
Citation Chang JS, Koom WS, Lee Y, Yoon HI, Lee HS. Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection? World J Gastroenterol 2014; 20(36): 12900-12907
URL http://www.wjgnet.com/1007-9327/full/v20/i36/12900.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i36.12900
Full Article (PDF) WJG-20-12900.pdf
Full Article (Word) WJG-20-12900.doc
Manuscript File 6793-Review.doc
Answering Reviewers 6793-Answering reviewers.pdf
Copyright License Agreement 6793-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6793-Language certificate.pdf
Peer-review Report 6793-Peer review.pdf
Scientific Editor Work List 6793-Scientific editor work list.doc